Huiling Li

Summary

Affiliation: Sanofi-Aventis Deutschland GmbH

Publications

  1. ncbi request reprint A pattern-mixture model for the analysis of censored quality-of-life data
    Huiling Li
    Clinical Biostatistics, Sanofi Aventis, 200 Crossings Blvd, P O Box 6890, Bridgewater, NJ 08807, USA
    Stat Med 25:1533-46. 2006
  2. ncbi request reprint Bayesian estimation of cost-effectiveness: an importance-sampling approach
    Daniel F Heitjan
    Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia 19104 6021, USA
    Health Econ 13:191-8. 2004
  3. ncbi request reprint Bayesian estimation of cost-effectiveness from censored data
    Daniel F Heitjan
    Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, 622 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104 6021, U S A
    Stat Med 23:1297-309. 2004

Collaborators

Detail Information

Publications3

  1. ncbi request reprint A pattern-mixture model for the analysis of censored quality-of-life data
    Huiling Li
    Clinical Biostatistics, Sanofi Aventis, 200 Crossings Blvd, P O Box 6890, Bridgewater, NJ 08807, USA
    Stat Med 25:1533-46. 2006
    ..We apply the method to data from the Randomized Evaluation of Mechanical Assistance in the Treatment of Congestive Heart Failure (REMATCH) clinical trial...
  2. ncbi request reprint Bayesian estimation of cost-effectiveness: an importance-sampling approach
    Daniel F Heitjan
    Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia 19104 6021, USA
    Health Econ 13:191-8. 2004
    ..The example demonstrates that the method is practical and provides for a flexible data analysis...
  3. ncbi request reprint Bayesian estimation of cost-effectiveness from censored data
    Daniel F Heitjan
    Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, 622 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104 6021, U S A
    Stat Med 23:1297-309. 2004
    ..We summarize the posterior distributions of key parameters by importance sampling. We illustrate the method with an analysis of data from a randomized clinical trial of a treatment for cardiovascular disease...